Senior insider sale
Chief Medical Officer at BICARA THERAPEUTICS INC. — senior position signals high conviction
$409.8K
22K shares
What this filing means
RABEN DAVID plans to sell 22K shares of BICARA THERAPEUTICS INC. valued at approximately $409.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/25/2026ACC: 0001969223-26-000395
Officer· Chief Medical Officer
Since Mar 2026
22K
Shares to sell
$409.8K
Approx. market value
5.50K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
3/25/2026
5.50KTotal acquired5.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/25/2026 | Exercise of Stock Options Cash | 5.50K | — |
| Total | 5.50K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
16.30K
Market value
$301.9K
3/4/2026
—Completed
Units to sell
200.00
Market value
$3.7K
3/3/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
5.50K
Market value
$104.2K
3/25/2026
Total
Units
22K
Value
$409.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/4/2026 | 16.30K | $301.9K | — | Completed |
3/3/2026 | 200.00 | $3.7K | — | Completed |
| Planned — Approximate Date | ||||
3/25/2026 | 5.50K | $104.2K | Nasdaq | Planned |
| Total | 22K | $409.8K | ||